azd0466 is new drug. Has NEVER been APPROVED. Astra do not have a previously APPROVED bcl2 drug. So I think you and AB are very CONFUSED. it us not my OPINIONS of drug trial success rate it is MIT. Do you doubt that is credible?
so I don’t need “objective data” to inform of your MISUNDERSTANDING.
so far we do not have STATISTCAL meaningful data from any clinical study showing DEP can improve anything all we have is a few feel good stories from jacky and some promising signs. But SLOW progress on dep docetaxel not look good.
.
Webinar this Friday 8th April with Jackie Fairley, page-64
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.5¢ | 9.5¢ | $8.154K | 83.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5102 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 124847 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |